275 related articles for article (PubMed ID: 21658868)
1. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
[TBL] [Abstract][Full Text] [Related]
3. An azole-resistant isolate of Malassezia pachydermatis.
Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
[TBL] [Abstract][Full Text] [Related]
4. Antifungal activities of azole agents against the Malassezia species.
Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
[TBL] [Abstract][Full Text] [Related]
6. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
[TBL] [Abstract][Full Text] [Related]
7. Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
Kano R; Yokoi S; Kariya N; Oshimo K; Kamata H
Med Mycol; 2019 Apr; 57(3):346-350. PubMed ID: 29800467
[TBL] [Abstract][Full Text] [Related]
8. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
[TBL] [Abstract][Full Text] [Related]
9. High multi-azole-resistant Malassezia pachydermatis clinical isolates from canine Malassezia dermatitis.
Kano R; Aramaki C; Murayama N; Mori Y; Yamagishi K; Yokoi S; Kamata H
Med Mycol; 2020 Feb; 58(2):197-200. PubMed ID: 31329927
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the antifungal susceptibility of Malassezia pachydermatis in various media using a CLSI protocol.
Cafarchia C; Figueredo LA; Favuzzi V; Surico MR; Colao V; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Oct; 159(3-4):536-40. PubMed ID: 22622336
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of voriconazole, fluconazole, itraconazole and amphotericin B against non Candida albicans yeast isolates.
Swinne D; Watelle M; Nolard N
Rev Iberoam Micol; 2005 Mar; 22(1):24-8. PubMed ID: 15813679
[TBL] [Abstract][Full Text] [Related]
12. In vitro combination of antifungal agents against Malassezia pachydermatis.
Schlemmer KB; de Jesus FPK; Loreto ES; Farias JB; Alves SH; Ferreiro L; Santurio JM
Med Mycol; 2019 Apr; 57(3):324-327. PubMed ID: 29924372
[TBL] [Abstract][Full Text] [Related]
13. Voriconazole against fluconazole-susceptible and resistant candida isolates: in-vitro efficacy compared with that of itraconazole and ketoconazole.
Nguyen MH; Yu CY
J Antimicrob Chemother; 1998 Aug; 42(2):253-6. PubMed ID: 9738846
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and genetic diversity of azole-resistant Malassezia pachydermatis isolates from canine otitis and dermatitis: A 2-year study.
Álvarez-Pérez S; Quevedo-Caraballo S; García ME; Blanco JL
Med Mycol; 2024 May; 62(5):. PubMed ID: 38734886
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of Malassezia pachydermatis isolates from canine skin with atopic dermatitis to ketoconazole and itraconazole in East Asia.
Watanabe S; Koike A; Kano R; Nagata M; Chen C; Hwang CY; Hasegawa A; Kamata H
J Vet Med Sci; 2014 Apr; 76(4):579-81. PubMed ID: 24334863
[TBL] [Abstract][Full Text] [Related]
16. Head-to-head comparison of inhibitory and fungicidal activities of fluconazole, itraconazole, voriconazole, posaconazole, and isavuconazole against clinical isolates of Trichosporon asahii.
Hazirolan G; Canton E; Sahin S; Arikan-Akdagli S
Antimicrob Agents Chemother; 2013 Oct; 57(10):4841-7. PubMed ID: 23877683
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Garau M; Pereiro M; del Palacio A
Antimicrob Agents Chemother; 2003 Jul; 47(7):2342-4. PubMed ID: 12821494
[TBL] [Abstract][Full Text] [Related]
18. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
Rojas FD; Sosa Mde L; Fernández MS; Cattana ME; Córdoba SB; Giusiano GE
Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain.
Cuenca-Estrella M; Díaz-Guerra TM; Mellado E; Monzón A; Rodríguez-Tudela JL
Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):432-5. PubMed ID: 10442422
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of E-test and CLSI methods for Itraconazole, Fluconazole and Ketoconazole susceptibilities of Microsporum canis strains.
Aneke CI; Rhimi W; Otranto D; Cafarchia C
Mycopathologia; 2020 Jun; 185(3):495-502. PubMed ID: 32468154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
